BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 28002801)

  • 1. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
    Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.
    Schröck A; Bode M; Göke FJ; Bareiss PM; Schairer R; Wang H; Weichert W; Franzen A; Kirsten R; van Bremen T; Queisser A; Kristiansen G; Heasley L; Bootz F; Lengerke C; Perner S
    Carcinogenesis; 2014 Jul; 35(7):1636-42. PubMed ID: 24743512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
    Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
    BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma.
    Bayo P; Jou A; Stenzinger A; Shao C; Gross M; Jensen A; Grabe N; Mende CH; Rados PV; Debus J; Weichert W; Plinkert PK; Lichter P; Freier K; Hess J
    Mol Oncol; 2015 Oct; 9(8):1704-19. PubMed ID: 26040981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC.
    Ohmura G; Tsujikawa T; Yaguchi T; Kawamura N; Mikami S; Sugiyama J; Nakamura K; Kobayashi A; Iwata T; Nakano H; Shimada T; Hisa Y; Kawakami Y
    Mol Cancer Res; 2015 Apr; 13(4):721-31. PubMed ID: 25421751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage.
    Thierauf J; Weissinger SE; Veit JA; Affolter A; Laureano NK; Beutner D; Heiduschka G; Kadletz L; Meyer M; Quaas A; Plinkert P; Hoffmann TK; Hess J
    PLoS One; 2018; 13(3):e0194989. PubMed ID: 29596469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
    Deng P; Wang J; Zhang X; Wu X; Ji N; Li J; Zhou M; Jiang L; Zeng X; Chen Q
    Carcinogenesis; 2018 Jul; 39(7):937-947. PubMed ID: 29741610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
    Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
    Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.
    Linxweiler M; Linxweiler J; Barth M; Benedix J; Jung V; Kim YJ; Bohle RM; Zimmermann R; Greiner M
    Am J Pathol; 2012 Feb; 180(2):473-83. PubMed ID: 22197383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity.
    Züllig L; Roessle M; Weber C; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H; Huber GF
    Eur J Cancer; 2013 May; 49(8):1915-22. PubMed ID: 23414798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.
    Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS
    Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
    Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
    BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients.
    Kühn JP; Bochen F; Körner S; Schick B; Wagner M; Smola S; Berkó-Göttel B; Morris LGT; Wang J; Bozzato A; Linxweiler M
    Int J Biol Markers; 2022 Sep; 37(3):280-288. PubMed ID: 35880270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.
    Lerner C; Wemmert S; Bochen F; Kulas P; Linxweiler M; Hasenfus A; Heinzelmann J; Leidinger P; Backes C; Meese E; Urbschat S; Schick B
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):757-66. PubMed ID: 26621153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
    Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
    Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis.
    Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S
    Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.